Nutritional intervention for improving treatment tolerance in cancer patients

A Paccagnella, I Morassutti, G Rosti - Current opinion in oncology, 2011 - journals.lww.com
Supplementation with ω3 fatty acids appears to offer benefits that are verifiable at a
biochemical, clinical and functional level. Related literature, however, provides conflicting …

[HTML][HTML] GDF15/GFRAL pathway as a metabolic signature for cachexia in patients with cancer

DS Ahmed, S Isnard, J Lin, B Routy, JP Routy - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Cachexia is a metabolic mutiny that directly reduces life expectancy in chronic conditions
such as cancer. The underlying mechanisms associated with cachexia involve inflammation …

Cachexia: a new definition

WJ Evans, JE Morley, J Argilés, C Bales, V Baracos… - Clinical nutrition, 2008 - Elsevier
On December 13th and 14th a group of scientists and clinicians met in Washington, DC, for
the cachexia consensus conference. At the present time, there is no widely agreed upon …

Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme

MJ McGirt, D Mukherjee, KL Chaichana, KD Than… - …, 2009 - journals.lww.com
OBJECTIVE Balancing the benefits of extensive tumor resection with the consequence of
potential postoperative deficits remains a challenge in malignant astrocytoma surgery …

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

DS Hong, D Hui, E Bruera, F Janku, A Naing… - The Lancet …, 2014 - thelancet.com
Background Inflammation is an important feature of the malignant phenotype and promotes
angiogenesis, tumour invasiveness, metastases, and cachexia. We used a first-in-class …

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

L Lerner, TG Hayes, N Tao, B Krieger… - Journal of cachexia …, 2015 - Wiley Online Library
Background Cancer‐related weight loss is associated with increased inflammation and
decreased survival. The novel inflammatory mediator growth differentiation factor (GDF) 15 …

Quality of life after breast cancer diagnosis and survival

M Epplein, Y Zheng, W Zheng, Z Chen, K Gu… - Journal of Clinical …, 2011 - ascopubs.org
Purpose To examine the association of quality of life (QOL) after diagnosis of breast cancer
with mortality and recurrence. Patients and Methods From 2002 to 2004, a total of 2,230 …

Quality of life scores predict survival among patients with head and neck cancer

CA Karvonen-Gutierrez, DL Ronis… - Journal of Clinical …, 2008 - ascopubs.org
Purpose The purpose of this study was to examine whether quality of life (QOL) scores
predict survival among patients with head and neck cancer, controlling for demographic …

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia

MD DeBoer, XX Zhu, P Levasseur, MM Meguid… - …, 2007 - academic.oup.com
Cancer cachexia is a debilitating syndrome of anorexia and loss of lean body mass that
accompanies many malignancies. Ghrelin is an orexigenic hormone with a short half-life that …

Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients

M Trajkovic-Vidakovic, A de Graeff, EE Voest… - Critical reviews in …, 2012 - Elsevier
PURPOSE: To determine the prognostic meaning of symptoms in patients with advanced
cancer. DESIGN: Medline, Embase, Cochrane and Cinahl databases were systematically …